ETNB - Akero plummets after mid-stage data for NASH candidate
2023-10-10 07:35:13 ET
More on Akero
- Akero Therapeutics: An Assessment
- Biggest stock movers today: Hyatt Hotels, PagerDuty and more
- Cantor starts Akero at buy, bullish on upcoming data for NASH drug
- Seeking Alpha’s Quant Rating on Akero Therapeutics
- Historical earnings data for Akero Therapeutics
For further details see:
Akero plummets after mid-stage data for NASH candidate